Literature DB >> 10744689

Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor.

C M Rondinone1, E Carvalho, T Rahn, V C Manganiello, E Degerman, U P Smith.   

Abstract

Phosphatidylinositol 3-kinase mediates several actions of insulin including its antilipolytic effect. This effect is elicited by the insulin-stimulated serine phosphorylation and activation of cGMP-inhibited phosphodiesterase (PDE3B). In human adipocytes, we found that insulin differentially stimulated phosphatidylinositol 3-kinase activity; the lipid kinase activity was associated with IRS-1, whereas the serine kinase activity was associated with the insulin receptor and phosphorylated a number of proteins including p85, p110, and a 135-kDa protein identified as PDE3B. PDE3B phosphorylation was associated with enzyme activation, thus initiating the antilipolytic effect of insulin. These results show a novel pathway for intracellular signaling through the insulin receptor leading to the serine phosphorylation of key proteins involved in insulin action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744689     DOI: 10.1074/jbc.275.14.10093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes.

Authors:  A Tirosh; A Rudich; R Potashnik; N Bashan
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

3.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  A phosphoprotein helps lipid droplets stay in shape.

Authors:  Martin J Spiering
Journal:  J Biol Chem       Date:  2020-07-17       Impact factor: 5.157

6.  Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase.

Authors:  P B Iynedjian; R A Roth; M Fleischmann; A Gjinovci
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

7.  Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.

Authors:  Faiyaz Ahmad; Weixing Shen; Fabrice Vandeput; Nicolas Szabo-Fresnais; Judith Krall; Eva Degerman; Frank Goetz; Enno Klussmann; Matthew Movsesian; Vincent Manganiello
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

8.  Phosphatidylinositol 3-kinase is an upstream regulator of the phosphodiesterase 3B pathway of leptin signalling that may not involve activation of Akt in the rat hypothalamus.

Authors:  A Sahu; K Koshinaka; M Sahu
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

Review 9.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.